ALIGN TECHNOLOGY, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
ALIGN TECHNOLOGY, INC. (ALGN) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $20.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $10.57M, a 5.75% increase year-over-year.
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $10.06M, a 6.40% increase year-over-year.
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $10.24M, a 4.10% increase year-over-year.
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $10.05M, a 5.06% increase year-over-year.
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $39.74M, a 3.39% increase from fiscal 2024.
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $38.44M, a 16.10% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $33.11M, a 8.48% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $30.52M, a 13.85% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $20.64M 10-Q · filed 2026-08-05 | $30.88M derived: sum of 3 quarters · filed 2026-08-05 | $40.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $10.06M 10-Q · filed 2026-05-06 | $20.30M derived: sum of 2 quarters · filed 2026-05-06 | $30.35M derived: sum of 3 quarters · filed 2026-05-06 | $40.35M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $10.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $20.29M derived: sum of 2 quarters · filed 2026-02-27 | $30.29M derived: sum of 3 quarters · filed 2026-08-05 | $39.74M 10-K · filed 2026-02-27 |
| 2025-09-30 | $10.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $20.05M derived: sum of 2 quarters · filed 2026-08-05 | $29.50M 10-Q · filed 2025-11-05 | $39.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $19.46M 10-Q · filed 2026-08-05 | $29.29M derived: sum of 3 quarters · filed 2026-08-05 | $38.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $9.46M 10-Q · filed 2026-05-06 | $19.29M derived: sum of 2 quarters · filed 2026-05-06 | $28.86M derived: sum of 3 quarters · filed 2026-05-06 | $38.28M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $9.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $19.40M derived: sum of 2 quarters · filed 2026-02-27 | $28.83M derived: sum of 3 quarters · filed 2026-02-27 | $38.44M 10-K · filed 2026-02-27 |
| 2024-09-30 | $9.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $18.99M derived: sum of 2 quarters · filed 2025-11-05 | $28.60M 10-Q · filed 2025-11-05 | $37.68M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $9.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $19.04M 10-Q · filed 2025-08-06 | $28.11M derived: sum of 3 quarters · filed 2026-02-27 | $36.62M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $9.61M 10-Q · filed 2025-05-08 | $18.68M derived: sum of 2 quarters · filed 2026-02-27 | $27.19M derived: sum of 3 quarters · filed 2026-02-27 | $34.96M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $9.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.58M derived: sum of 2 quarters · filed 2026-02-27 | $25.35M derived: sum of 3 quarters · filed 2026-02-27 | $33.11M 10-K · filed 2026-02-27 |
| 2023-09-30 | $8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $16.28M derived: sum of 2 quarters · filed 2024-11-05 | $24.03M 10-Q · filed 2024-11-05 | $31.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $7.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $15.53M 10-Q · filed 2024-08-02 | $23.30M derived: sum of 3 quarters · filed 2025-02-28 | $30.98M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $7.75M 10-Q · filed 2024-05-03 | $15.52M derived: sum of 2 quarters · filed 2025-02-28 | $23.20M derived: sum of 3 quarters · filed 2025-02-28 | $30.75M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $7.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $15.45M derived: sum of 2 quarters · filed 2025-02-28 | $22.99M derived: sum of 3 quarters · filed 2025-02-28 | $30.52M 10-K · filed 2025-02-28 |
| 2022-09-30 | $7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $15.23M derived: sum of 2 quarters · filed 2023-11-03 | $22.76M 10-Q · filed 2023-11-03 | $30.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $7.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $15.07M 10-Q · filed 2023-08-04 | $22.52M derived: sum of 3 quarters · filed 2024-02-28 | $29.47M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $7.53M 10-Q · filed 2023-05-05 | $14.97M derived: sum of 2 quarters · filed 2024-02-28 | $21.92M derived: sum of 3 quarters · filed 2024-02-28 | $28.42M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $14.39M derived: sum of 2 quarters · filed 2024-02-28 | $20.90M derived: sum of 3 quarters · filed 2024-02-28 | $26.81M 10-K · filed 2024-02-28 |
| 2021-09-30 | $6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $13.45M derived: sum of 2 quarters · filed 2022-11-04 | $19.36M 10-Q · filed 2022-11-04 | $25.01M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $12.41M 10-Q · filed 2022-08-04 | $18.06M derived: sum of 3 quarters · filed 2023-02-27 | $23.73M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $5.91M 10-Q · filed 2022-05-05 | $11.56M derived: sum of 2 quarters · filed 2023-02-27 | $17.23M derived: sum of 3 quarters · filed 2023-02-27 | $22.83M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $11.32M derived: sum of 2 quarters · filed 2023-02-27 | $16.92M derived: sum of 3 quarters · filed 2023-02-27 | $22.47M 10-K · filed 2023-02-27 |
| 2020-09-30 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $11.27M derived: sum of 2 quarters · filed 2021-11-02 | $16.82M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $11.15M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $5.55M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $18.48M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |